Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
By H. Schumacher, M. Becker, R. Wortmann, P. Macdonald, B. Hunt, Janet Streit, C. Lademacher, N. Joseph‐Ridge. Arthritis & Rheumatism, 2008
632 citations recorded by the source corpus.
Subfields: Hepatology, Nephrology, Surgery
View Paper: https://www.semanticscholar.org/paper/123f98855e8f080c2470d0dcb7514ff949694c5c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Nephrology
Citations in the corpus
- Uric acid and chronic kidney disease: which is chasing which? (2013, background): “For example, one randomized doubleblind trial [80] comprised 1072 patients with gout, serum uric acid >8 mg/dL and either normal serum creatinine or serum creatinine 1.”